Balanced Rock Investment Advisor Sc Pharmaceuticals Inc. Transaction History
Balanced Rock Investment Advisor
- $117 Billion
- Q1 2024
A detailed history of Balanced Rock Investment Advisor transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Balanced Rock Investment Advisor holds 57,248 shares of SCPH stock, worth $243,304. This represents 0.25% of its overall portfolio holdings.
Number of Shares
57,248
Previous 52,421
9.21%
Holding current value
$243,304
Previous $329 Million
12.56%
% of portfolio
0.25%
Previous 0.29%
Shares
2 transactions
Others Institutions Holding SCPH
# of Institutions
81Shares Held
26.6MCall Options Held
101KPut Options Held
13.9K-
Orbimed Advisors LLC San Diego, CA5.56MShares$23.6 Million0.63% of portfolio
-
Rubric Capital Management LP New York, NY3.53MShares$15 Million0.6% of portfolio
-
Aigh Capital Management LLC Baltimore, MD3.39MShares$14.4 Million6.86% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$7.66 Million0.0% of portfolio
-
King Luther Capital Management Corp Fort Worth, TX1.45MShares$6.18 Million0.03% of portfolio
About scPharmaceuticals Inc.
- Ticker SCPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,402,100
- Market Cap $116M
- Description
- scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...